Clinical Trial Update: Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on tranexamic acid for residual chronic subdural hematoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Unity Health Toronto | Conditions: Chronic Subdural Hematoma | Phase 3 | Status: UNKNOWN